SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-070064
Filing Date
2023-08-23
Accepted
2023-08-23 06:10:14
Documents
23
Period of Report
2023-08-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea184106-6k_biondvax.htm 6-K 9963
2 BIONDVAX PRESENTATION, DATED AUGUST 2023 ea184106ex99-1_biondvax.htm EX-99.1 30215
3 GRAPHIC ex99-1_001.jpg GRAPHIC 111686
4 GRAPHIC ex99-1_002.jpg GRAPHIC 270711
5 GRAPHIC ex99-1_003.jpg GRAPHIC 211137
6 GRAPHIC ex99-1_004.jpg GRAPHIC 211353
7 GRAPHIC ex99-1_005.jpg GRAPHIC 147220
8 GRAPHIC ex99-1_006.jpg GRAPHIC 187277
9 GRAPHIC ex99-1_007.jpg GRAPHIC 86687
10 GRAPHIC ex99-1_008.jpg GRAPHIC 169321
11 GRAPHIC ex99-1_009.jpg GRAPHIC 183860
12 GRAPHIC ex99-1_010.jpg GRAPHIC 122068
13 GRAPHIC ex99-1_011.jpg GRAPHIC 135201
14 GRAPHIC ex99-1_012.jpg GRAPHIC 155965
15 GRAPHIC ex99-1_013.jpg GRAPHIC 172337
16 GRAPHIC ex99-1_014.jpg GRAPHIC 121386
17 GRAPHIC ex99-1_015.jpg GRAPHIC 181538
18 GRAPHIC ex99-1_016.jpg GRAPHIC 225902
19 GRAPHIC ex99-1_017.jpg GRAPHIC 180637
20 GRAPHIC ex99-1_018.jpg GRAPHIC 250898
21 GRAPHIC ex99-1_019.jpg GRAPHIC 148837
22 GRAPHIC ex99-1_020.jpg GRAPHIC 111522
23 GRAPHIC ex99-1_021.jpg GRAPHIC 87052
  Complete submission text file 0001213900-23-070064.txt   4826335
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 231195088
SIC: 2836 Biological Products, (No Diagnostic Substances)